companydata.dkcompanydata.dk

Gefjon Pharma ApS: Financial statements 2026

CVR: 44512971

Source: annual report 2026, Danish Business Authority

01/04/202531/03/2026

Gefjon Pharma ApS (CVR 44512971) has filed annual accounts for 2026. In 2026, the company reported a gross profit of DKK -2,230,382 and a net result of DKK -4,245,453. Equity in the 2026 report amounted to DKK -4,998,334. The company had 5 employees in the financial year.

Gross Profit
DKK -2,230,382
Profit/Loss
DKK -4,245,453
Equity
DKK -4,998,334
Total Assets
DKK 7,867,883
Employees
5

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like Gefjon Pharma ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2026

Gefjon Pharma ApS updates contact informationJun 12, 2026

Contact info changed: new phone: 50899528, new email: [email protected], new website: www.gefjonpharma.com (June 12, 2026).

Gefjon Pharma ApS appoints new auditorJun 10, 2026

As of June 10, 2026, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Gefjon Pharma ApS.

Gefjon Pharma ApS updates contact informationFeb 4, 2026

Contact info changed: new phone: 50899528, new email: [email protected], new website: www.gefjonpharma.com (February 4, 2026).

Thomas Frees Buthler joins the board of Gefjon Pharma ApSFeb 3, 2026

As of February 3, 2026, Thomas Frees Buthler has joined the board of directors of Gefjon Pharma ApS.

Anders Miki Bojesen joins the board of Gefjon Pharma ApSFeb 3, 2026

As of February 3, 2026, Anders Miki Bojesen has joined the board of directors of Gefjon Pharma ApS.

Torben Hald joins the board of Gefjon Pharma ApSFeb 3, 2026

As of February 3, 2026, Torben Hald has joined the board of directors of Gefjon Pharma ApS.

Fabio Antenucci joins the board of Gefjon Pharma ApSFeb 3, 2026

As of February 3, 2026, Fabio Antenucci has joined the board of directors of Gefjon Pharma ApS.

About Gefjon Pharma ApS

Gefjon Pharma ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2023. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Torben Hald, Anders Miki Bojesen and Fabio Antenucci. The board consists of Anders Miki Bojesen (chair), Fabio Antenucci, Thomas Frees Buthler and Torben Hald. The company's owners include Copenhagen Equity ApS, North2k ApS and TBU Holding 2023 ApS. According to the 2026 annual report, the company had an average of 5 employees. In 2026, the company reported a gross profit of DKK -2,230,382 and a net result of DKK -4,245,453. Equity in the 2026 report amounted to DKK -4,998,334.

Source: annual report 2026, Danish Business Authority